Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-22

Clinical Trial Update: Tissue Biomarker for Pegvisomant Action [NA]

View source ↗

Summary

A completed trial update investigating tissue biomarkers related to Pegvisomant action in acromegaly; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegvisomant (pegvisomant)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Acromegaly | NA | Status: COMPLETED | Results posted: 2017-08-22